ReShape Lifesciences rises on all-stock merger agreement

Vyome Holdings

09/07/2024 15:24

** Shares of metabolic health solutions co ReShape
Lifesciences  RSLS.O  rise 9% to 22 cents
    ** Co announces definitive merger agreement to combine with
Vyome Therapeutics in an all-stock merger
    ** Under the terms of the deal, existing ReShape
stockholders will own about 11.1% of the combined company,
following the closing of the merger
    ** At the closing of the merger, ReShape will be renamed
Vyome Holdings Inc. and expects to trade under the Nasdaq ticker
symbol "HIND"
    ** Co also entered into an asset purchase agreement with
med-tech co Biorad Medisys to sell its assets for $5.16 million
in cash
    ** Including session moves, stock down 6.6% YTD

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))